AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
LEVOFLOXACIN HEMIHYDRATE in Malawi
7 products registered with PMRA — 0 active, 7 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LEVIMIK 500MG TABLETS TABLETS | PMPB/PL466/4 | — | expired | 31 Mar 2024 |
| LEVIN 500MG TABLET TABLET | PMPB/PL401/35 | — | expired | 30 Jun 2021 |
| LEVIN-250 250MG TABLET TABLET | PMPB/PL401/36 | — | expired | 30 Jun 2021 |
| SAFELEVO_750 750MG TABLET TABLET | PMPB/PL426/14 | — | expired | 30 Jun 2021 |
| SAFELEVO_500 500MG TABLET TABLET | PMPB/PL426/13 | — | expired | 30 Jun 2021 |
| LEVO_G_750 750MG TABLET TABLET | PMPB/PL459/3 | — | expired | 30 Jun 2021 |
| LEVOBACT-750 750MG FILM-COATED TABLETS FILM-COATED TABLETS | PMPB/PL106/18 | — | expired | 30 Jun 2019 |
LEVOFLOXACIN HEMIHYDRATE — PMRA Registration Details
PMRA (Malawi) has 7 registered products containing LEVOFLOXACIN HEMIHYDRATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track LEVOFLOXACIN HEMIHYDRATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.